Related Experiment Video
Updated: Jul 6, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Predicting survival in patients with advanced disease
Paul Glare1, Christian Sinclair, Michael Downing
1Department of Palliative Care, Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. paul@email.cs.nsw.gov.au
European Journal of Cancer (Oxford, England : 1990)
|April 9, 2008
Summary
Accurate cancer prognostication aids clinical decisions. Combining clinician judgment with validated tools improves survival predictions for advanced cancer patients, enhancing care delivery.
Area of Science:
- Oncology
- Palliative Care
- Clinical Medicine
Background:
- Prognostication is crucial for advanced cancer care but clinicians face challenges in accuracy and communication.
- Understanding the trajectory of advanced cancer, including gradual decline followed by accelerated decline, is key.
- Recognizing indicators of the final phase, such as poor performance status and specific symptoms, aids prognostication.
Purpose of the Study:
- To explore accurate methods for formulating cancer prognoses.
- To investigate effective communication strategies for delivering prognostic information.
- To highlight the importance of prognostication in clinical decision-making for cancer patients.
Main Methods:
- Review of clinical indicators and patient decline patterns in advanced cancer.
- Analysis of clinician biases and the effectiveness of different prediction methods (probabilistic vs. temporal).
- Evaluation of validated prognostic tools and their combination with subjective clinical judgment.
Main Results:
- Probabilistic predictions are more accurate than temporal predictions for cancer survival.
- Validated prognostic tools, especially when combined with clinical judgment, enhance prediction accuracy.
- Specific clinical and laboratory parameters indicate the final phase of decline in advanced cancer.
Conclusions:
- Accurate prognostication requires a combination of clinical experience and validated tools.
- Effective communication of survival predictions, considering cultural nuances, is vital for patient care.
- Further research is needed on prognosis and its impact on clinical decisions in advanced cancer.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:24Kaplan-Meier Approach
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:20Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
01:15Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.